Melissa Adams: Daily
Clear-eyed analysis of the trends and technologies reshaping our future.
MA
Editor
Melissa Adams
About This Column
Melissa Adams is an expert commentator on the intersection of technology and human progress. Transitioning from her role as a healthcare innovation analyst, Melissa now brings her signature rigor to a wide array of topics that define our era. She specializes in cutting through the hype of "newness" to find the tangible impact on real people and bottom-line results. Her daily dispatches are essential for anyone who wants to understand the strategic and societal implications of a world in constant motion.
Displaying items 461-480 of 742 in total
Read full article
GLOBO Taps AI Veteran Ryan Toohil as CTO to Drive Tech Expansion
Read full article
Safe-Guard & Nissan Canada Renew Deal, Eyeing Data-Driven Protection
Read full article
AI Power Crisis Spurs Novel CO2 Battery Solution in West Texas
Read full article
Veterans United: An 11-Year Dynasty as a Top Workplace
Read full article
LibraryBub Highlights Data-Driven Accounting in New Indie Book Selection
Read full article
Railserve Unites Brands, Forging a Railyard Services Powerhouse
Read full article
Fairmont's New Adventures Redefine Ultra-Luxury Travel
Read full article
NSLC Earns Landmark Seal for Student Well-Being, Setting New Standard
Read full article
CITCO Water's Southern Surge Targets Aging Infrastructure
Read full article
Biom's New Wipe System: A One-Handed Revolution for Parents
Read full article
Canada's Seafood Farmers Push for Policy Overhaul to Unlock Growth
Read full article
LabConnect Upgrades Clinical Trial Logistics with SampleGISTICS 2.0
Read full article
aytm Taps Data Guru to Combat AI's Threat to Research Integrity
Read full article
Siemens USA Taps Veteran Ann Fairchild to Lead AI & Reshoring Push
Read full article
First Atom Aims to Revolutionize Drug Design with 'Zero-Shot' AI
Read full article
Beyond the Pill: How Logistics Powers Biotech's Multi-Disease Future
Read full article
AI-Powered Drug Cleared for Pediatric Brain Cancer Trial
Read full article
New Hope for EU Lung Cancer Patients as Taletrectinib Enters EMA Review
Read full article
US Market a Magnet for Global Firms Despite Regulatory Maze
Read full article
UCID: 24
